NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) (352165)
Applications due Oct 20, 2026
The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) (352163)
Applications due Oct 20, 2026
The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) (357493)
Applications due Oct 20, 2026
The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) grant invites applications for mid-phase clinical trials focusing on natural products such as botanicals and dietary supplements. It aims to advance scientific knowledge by determining optimal dosing and patient responses. Applicants must provide preliminary data demonstrating bioavailability and measurable impacts on target engagement. This initiative will not support efficacy trials for cancer treatments and encourages early contact with NCCIH scientific contacts.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) (357492)
Applications due Oct 20, 2026
The NCCIH Natural Product Early Phase Clinical Trial Award supports innovative clinical trials of natural products, such as botanicals and dietary supplements, with a strong scientific basis. Applications are encouraged to explore optimal delivery methods and combinations with other treatments. Funding is available for up to three years to assess the impact on target engagement and clinical outcomes, aiming to translate basic science findings into practical clinical applications.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) (357490)
Applications due Oct 20, 2026
The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33) invites research proposals for early phase clinical trials of natural products, including botanicals and dietary supplements, emphasizing scientific validity for further testing. Applicants may receive up to three years of funding for pharmacokinetics and bioavailability studies, with potential for an additional three years to evaluate clinical outcomes. This initiative aims to optimize natural product delivery through innovative study designs.
US Dept. of Health & Human Services: National Institutes of Health (NIH)
Laboratory Flexible Funding Model (LFFM)
Letter of inquiry due Dec 15, 2026
The Laboratory Flexible Funding Model (LFFM) aims to enhance state food testing laboratories' capabilities, supporting an integrated food safety system. By prioritizing sample testing and food defense preparedness in microbiology, chemistry, and radiochemistry, this cooperative agreement facilitates method development and expands testing capacity, ensuring safer food for consumers.
US Department of Health & Human Services: Food and Drug Administration (FDA)
US $250,000 - US $1,000,000
Specialty Crop Multi-State Program (SCMP)
Applications due Oct 16, 2026
The California Specialty Crop Multi-State Program, established by the California Department of Food and Agriculture, aims to enhance the competitiveness of specialty crops through funding collaborative projects addressing key issues like food safety and marketing. Grants range from $250,000 to $1 million, supporting initiatives that span up to three years. This program emphasizes the importance of specialty crops, including fruits, vegetables, and horticulture, in California's agricultural landscape.
California Department of Food & Agriculture
US $2,000,000 - US $7,500,000
Cold Chain Grants for Emergency Food Assistance
Applications due Oct 2, 2026
The Cold Chain Grants for Emergency Food Assistance, funded by the Agricultural Marketing Service, aim to support eligible organizations in enhancing cold storage capabilities within the food supply chain. This initiative focuses on providing essential nutrition assistance to low-income individuals through subawards to food banks and nonprofit organizations. By investing in cold storage equipment, the program seeks to improve the management and distribution of food resources, ensuring that vulnerable populations receive adequate support.
Agricultural Marketing Service